Concord Wealth Partners Lowers Stake in UnitedHealth Group Incorporated $UNH

Concord Wealth Partners lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 5,137 shares of the healthcare conglomerate’s stock after selling 313 shares during the period. Concord Wealth Partners’ holdings in UnitedHealth Group were worth $1,603,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Nuveen LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at $3,846,764,000. Vanguard Group Inc. boosted its holdings in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP boosted its holdings in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after buying an additional 2,486,839 shares in the last quarter. National Bank of Canada FI grew its position in UnitedHealth Group by 137.8% during the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after buying an additional 950,928 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after buying an additional 847,054 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Barclays boosted their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday. Robert W. Baird reissued an “underperform” rating and issued a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Finally, Truist Financial boosted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $383.09.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $354.30 on Monday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a 50 day moving average price of $318.21 and a 200 day moving average price of $348.08. The company has a market cap of $320.88 billion, a price-to-earnings ratio of 15.35, a PEG ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.